Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

STRIB BESLAGSMED ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   2.1% 2.1% 2.1% 2.1% 2.1% 2.1% 2.1% 2.1%   Bankruptcy risk   5.5% 5.9% 3.2% 3.8% 2.8% 4.1% 15.5% 15.5%   Credit score (0-100)   42 40 56 50 59 48 13 13   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   860 951 1,223 1,154 1,154 1,414 0.0 0.0   EBITDA   115 100 311 177 167 31.8 0.0 0.0   EBIT   6.7 3.0 223 66.0 69.3 -17.0 0.0 0.0   Pre-tax profit (PTP)   -6.1 -12.4 201.9 59.4 46.6 -20.2 0.0 0.0   Net earnings   -5.4 -10.5 143.2 45.6 35.6 -17.1 0.0 0.0   Pre-tax profit without non-rec. items   -6.1 -12.4 202 59.4 46.6 -20.2 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   300 246 505 393 344 52.8 0.0 0.0   Shareholders equity total   54.9 44.4 188 177 212 195 145 145   Interest-bearing liabilities   229 125 209 101 92.6 10.5 0.0 0.0   Balance sheet total (assets)   544 481 784 721 777 717 145 145   Net Debt   77.4 6.2 53.1 10.2 -150 -162 -145 -145     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   860 951 1,223 1,154 1,154 1,414 0.0 0.0   Gross profit growth   -4.1% 10.5% 28.6% -5.6% 0.0% 22.5% -100.0% 0.0%   Employees   2 2 3 3 3 4 0 0   Employee growth %   0.0% 0.0% 50.0% 0.0% 0.0% 33.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   544 481 784 721 777 717 145 145   Balance sheet change%   -18.2% -11.7% 63.0% -8.1% 7.8% -7.7% -79.8% 0.0%   Added value   115.2 100.4 311.3 177.3 180.5 31.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -217 -152 171 -223 -147 -340 -53 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   0.8% 0.3% 18.3% 5.7% 6.0% -1.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   1.5% 1.1% 35.9% 9.4% 9.3% -2.3% 0.0% 0.0%   ROI %   2.6% 2.6% 77.7% 20.0% 22.6% -6.3% 0.0% 0.0%   ROE %   -6.9% -21.2% 123.5% 25.0% 18.3% -8.4% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   10.1% 9.2% 23.9% 24.5% 27.3% 27.2% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   67.2% 6.2% 17.0% 5.7% -89.7% -507.7% 0.0% 0.0%   Gearing %   417.9% 282.4% 111.5% 56.9% 43.6% 5.4% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   7.0% 10.3% 15.1% 7.3% 23.5% 6.4% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   0.4 0.4 0.5 0.7 0.7 1.2 0.0 0.0   Current Ratio   0.6 0.6 0.6 0.8 0.8 1.3 0.0 0.0   Cash and cash equivalent   152.0 119.1 156.0 90.4 242.5 172.1 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -189.3 -190.6 -209.6 -105.0 -109.2 154.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   58 50 104 59 60 8 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   58 50 104 59 56 8 0 0   EBIT / employee   3 2 74 22 23 -4 0 0   Net earnings / employee   -3 -5 48 15 12 -4 0 0